pharma
Bracco International
Bracco International B.V.
Bracco International is a pharma organization headquartered in Amsterdam, NL. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov,
Company details
- Status
- Public
- HQ
- Amsterdam, NL
- Programs
- 0
- Drugs
- 0
- Patents
- 25
Bracco International patents
25 pharmaceutical patents indexed for Bracco International. 7 expire within 24 months.
Bracco International has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 7 expire within 24 months β use filters for patent-cliff planning.
Patent portfolio
-
IL 172160
Method for non-invasive quantification of perfusion in a tissue
granted -
EP 2117603
TARGETING UND THERAPEUTISCHE VERBINDUNGEN UND GASGEFΓLLTE MIKROVESIKEL MIT DIESEN VERBINDUNGEN
granted -
WO 2009076388
CONJUGUΓS VECTEUR DE CIBLAGE - PHOSPHOLIPIDE
granted -
CA 2670932
DETECTION DU DETACHEMENT D'UN AGENT DE CONTRASTE IMMOBILISE DANS DES APPLICATIONS D'IMAGERIE MEDICALE
granted -
US 2008107607
TARGETING VECTOR-PHOSPHOLIPID CONJUGATES
granted -
US 2008063603
ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM
granted -
CA 2631716
CONJUGUES VECTEUR DE CIBLAGE-PHOSPHOLIPIDES
granted -
US 2007128117
Ultrasound contrast agents and process for the preparation thereof
granted -
US 2007086944
CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
granted -
US 2006153775
Compounds for targeting endothelial cells, compositions containing the same and methods for their use
granted -
US RE39146
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
granted -
WO 2006031885
PEPTIDES DE LIAISON A LA REGION DU DOMAINE KINASE (KDR) ET AU COMPLEXE FACTEUR DE CROISSANCE ENDOTHELIALE VASCULAIRE/REGION DU DOMAINE KINASE (VEGF/KDR)
expired -
EP 1603935
SPEZIFISCH AN HGF-REZEPTOR (cMet) BINDENDE PEPTIDE UND DEREN VERWENDUNG
expired -
EP 1590006
ULTRASCHALL KONTRASTMITTEL UND VERFAHREN ZUR ERSTELLUNG
expired -
US 2005147555
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
expired -
US 2004208826
Ultrasound contrast agents and methods of making and using them
expired -
US 2004170566
Dual functioning excipient for metal chelate contrast agents
expired -
CA 2512780
PRODUITS DE SYNTHESE MULTIVALENTS POUR APPLICATIONS THERAPEUTIQUES ET DIAGNOSTIQUES
expired -
CA 2513044
PEPTIDES DE LIAISON KDR ET VEGF/KDR ET LEUR UTILISATION A DES FINS DIAGNOSTIQUES ET THERAPEUTIQUES
expired -
US 2004033243
SINCALIDE FORMULATIONS
expired -
US 2003194376
Ultrasound contrast agents and methods of making and using them
expired -
CA 2477935
PRODUITS DE SYNTHESE MULTIVALENTS POUR APPLICATIONS THERAPEUTIQUES ET DIAGNOSTIQUES
expired -
US 2003185759
Ultrasound contrast agents and methods of making and using them
expired -
US 2003175211
Ultrasound contrast agents and methods of making and using them
expired -
CA 2477836
PEPTIDES LIANT DES RECEPTEURS KDR ET VEGF/KDR ET LEURS UTILISATIONS EN DIAGNOSTIC ET THERAPIE
expired
Frequently asked questions
How many patents does Bracco International have?
25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Bracco International patents expire?
7 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.